News
Important Only
RPT-BREAKINGVIEWS-Tariffs reset weakens Trump’s hand in China talks
By Hudson Lockett HONG KONG, Feb 23 (Reuters Breakingviews) - Going toe-to-toe with an autocrat can be hard if you're only pretending at omnipotence. That is the lesson Donald Trump must keep in mind now that the Supreme Court has struck down most of the U.S. president's tariffs on import...Reuters
17 minutes ago
Pre-Bell | Wall St Futures Dip; Novo Nordisk Sinks 15%; Eli Lilly Gains 3%; Domino’s Pizza Jumps 5%; Arcellx Soars 78%
01 Stock MarketAs of Feb 23, U.S. stock index futures performed as follows: Dow-linked futures fell 0.34%, S&P 500 futures fell 0.39%, and Nasdaq 100 futures fell 0.58%. Tariff-related uncertainty weighed on risk appetite, with megacap tech pointing lower pre-bell while haven demand supported precio...Tiger News
17 minutes ago
Domino's beats US sales estimates as deals attract budget-conscious customers
By Anuja Bharat Mistry and Krisha Bhatt Feb 23 (Reuters) - Domino's Pizza DPZ.O beat Wall Street estimates for fourth-quarter U.S. same-store sales on Monday, as value-driven promotions and new menu items fueled demand, sending the pizza chain's shares up about 5% in premarket trading.Con...Reuters
18 minutes ago
Merck rises as drugmaker revamps human health business
Shares of drugmaker Merck MRK.N rise 1.5% to $124.10 premarket Co says it will split its human health operations into an Oncology unit and a Specialty, Pharma & Infectious Diseases unit to improve performance ahead of multiple product launches Co says Jannie Oosthuizen will lead oncology; Brian...Reuters
20 minutes ago
Fortune Brands rises on reported activist investor stake
Shares of building-products supplier Fortune Brands Innovations FBIN.N advancing 4% to $56.51 premarket after a WSJ report said investor Ed Garden built a stake and seeks to replace its incoming CEOGarden, who runs Garden Investments, has privately nominated director candidates and views the co'...Reuters
24 minutes ago
Merck to create separate cancer business to offset Keytruda patent loss
Feb 23 (Reuters) - Merck MRK.N said on Monday it will split its human-health business into two divisions, separating its blockbuster cancer franchise led by Keytruda from its non-oncology medicines.The shake-up comes as the drugmaker braces for the looming loss of exclusivity on Keytruda, which acco...Reuters
27 minutes ago
MORNING BID AMERICAS-Supreme uncertainty
By Mike Dolan Feb 23 - What matters in U.S. and global markets todayBy Mike Dolan, Editor-At-Large, Finance and Markets It’s fair to say financial markets are just as confused about U.S. trade policy as foreign leaders who are now left questioning which tariffs apply to their goods, for how ...Reuters
28 minutes ago
Jefferies trims Leidos PT on soft 2026 outlook
Jefferies cuts PT on defense contractor Leidos LDOS.N to $215 from $230, rating maintained at "buy" New PT implies an upside of 24% from the stock's last closeBrokerage flags soft 2026 outlook as the key overhang, pointing to continued weakness in health segment and the slip of several m...Reuters
30 minutes ago
BREAKINGVIEWS-EU’s best tariff move is to stall a weaker Trump
By Neil Unmack and Yawen ChenLONDON, Feb 23 (Reuters Breakingviews) - With the president’s key levies void, Europe could seek better terms on last year’s trade deal. Yet Washington’s leverage goes beyond its new 15% temporary tariff. Brussels’ best hope is to avoid escalation and buy time, in the ho...Reuters
31 minutes ago
Novo Nordisk slump wipes out last Wegovy-era gains after trial setback
Feb 23 (Reuters) - Novo Nordisk NOVOb.CO shares fell more than 15% on Monday, wiping away the last gains Wegovy's launch had brought, after the drugmaker said its next-generation obesity drug CagriSema underperformed Eli Lilly's LLY.N tirzepatide in a trial.The trial was designed to show Cag...Reuters
36 minutes ago
Arcellx soars as Gilead agrees to up to $7.8 billion acquisition
Shares of cancer therapy developer Arcellx ACLX.O surge 77.5% to $113.78 premarketGilead Sciences GILD.O says it will buy ACLX for an implied equity value of $7.8 billionThe offer includes $115 per share in cash and one contingent value right of $5 per shareShares of GILD were down 1.1% premarketUp ...Reuters
36 minutes ago
SNAPSHOT-India stocks, rupee, swaps, call at close
Feb 23 (Reuters) - STOCKS:The benchmark BSE Sensex .BSESN ended up 0.58% to 83,294.66, while the broader NSE Nifty 50 index .NSEI advanced 0.55% to 25,713, after the U.S. Supreme Court struck down President Donald Trump's sweeping tariffs, but the gains were capped as persistent concerns over th...Reuters
37 minutes ago
Merck rises; WSJ reports co to split cancer business ahead of Keytruda patent loss
Shares of drugmaker Merck MRK.N rise 1.41% to $123.98 premarketMRK is creating a separate cancer business as it prepares for its top-selling cancer drug Keytruda to lose U.S. patent protection in 2028 - the Wall Street JournalMRK's Keytruda brings in nearly half of Merck's sales and could fa...Reuters
43 minutes ago
Vanda Pharma jumps as US FDA approves new antipsychotic pill
Shares of Vanda Pharmaceuticals VNDA.O rise 37% to $7.91 premarketOn late Friday, the U.S. FDA approved VNDA's drug for the treatment of two serious mental health conditionsThe drug, Bysanti, is an antipsychotic pill aimed at treating schizophrenia and acute bipolar I disorderMarket exclusivity ...Reuters
45 minutes ago
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
Feb 23 (Reuters) - Gilead Sciences GILD.O said on Monday it will buy cancer therapy partner Arcellx ACLX.O for an implied equity value of $7.8 billion, expanding their cell therapy development collaboration that started in 2022.Shares of Arcellx climbed 77.8% to $113.99 while Gilead fell about 1% in...Reuters
47 minutes ago
Jefferies downgrades Deere to 'underperform'; shares fall
Shares of tractor maker Deere & Co DE.N fall ~1.3% in premarketJefferies downgrades stock rating to "underperform" from "hold"Says while the agricultural cycle should trough this year, recovery will require an improvement in US farmer incomes, with crop prices the key driverBroke...Reuters
51 minutes ago
Novo Nordisk slumps to almost 5-yr lows after obesity drug trial disappoints investors
Shares in Novo Nordisk NOVOb.CO slump 16% after the Danish pharmaceutical giant said its experimental obesity drug failed to meet the primary endpoint in a trial designed to show non-inferiority to Eli Lilly's LLY.N tirzepatide in reducing weight*Novo Nordisk said CagriSema achieved a 23% reduct...Reuters
52 minutes ago
Silver miners gain as metal prices edge higher on weak US dollar
U.S.-listed shares of silver miners gain premarket, tracking rising prices of the metal GOL/Spot silver XAG= up 2.6% at $86.73/ounce, its highest in more than two weeksSilver prices gain as the U.S. Supreme Court ruling against President Donald Trump's tariffs sent the dollar lowerHecla Mining H...Reuters
54 minutes ago
LIVE MARKETS-Miners' capex signals keep BofA wary on equipment makers
STOXX 600 down 0.2%Traders assess U.S. tariff fall-outHealthcare names sinkLuxury stocks riseWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com MINERS' CAPEX SIGNALS KEEP BOFA W...Reuters
55 minutes ago
Arcellx soars after Gilead to acquire co for $7.8 billion
Shares of cancer therapy developer Arcellx ACLX.O rise 77.5% to $113.78 premarketGilead Sciences GILD.O says it will buy ACLX for an implied equity value of $7.8 billionThe implied equity value includes $115 per share in cash at closing and one contingent value right of $5 per shareUp to last close,...Reuters
an hour ago
